<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01211912</url>
  </required_header>
  <id_info>
    <org_study_id>10-003283</org_study_id>
    <nct_id>NCT01211912</nct_id>
  </id_info>
  <brief_title>Acetaminophen Transfer Across the Placenta and the Assessment of Fetal Well-being</brief_title>
  <official_title>Acetaminophen Transfer Across the Placenta and the Assessment of Fetal Well-being</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study has two aims:

        1. to evaluate placental transfer of acetaminophen from mother to baby transplacentally
           given from 30 minutes to 24 hours prior to cesarean delivery (34 patients)

        2. to understand the impact of maternal acetaminophen use on fetal movement and breathing
           (20 patients)
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maternal and neonatal serum acetaminophen level</measure>
    <time_frame>Time Frame: 30 minutes to 24 hours post administration</time_frame>
    <description>Pregnant women will be given 1000 mg of acetaminophen orally and have both maternal and neonatal serum acetaminophen levels checked at the time of cesarean section 30 minutes to 24 hours after administration.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fetal breathing and body movements</measure>
    <time_frame>Time Frame: 60 minutes</time_frame>
    <description>Pregnant women will have a baseline assessment of fetal breathing and body movements with ultrasound and will then be given 1000 mg of acetaminophen orally. Fetal breathing and body movements will then be reassessed 60 minutes later.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Fetal Testing</condition>
  <condition>Transplacental Transfer of Acetaminophen</condition>
  <arm_group>
    <arm_group_label>Arm 1 (20 patients)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pregnant women will be given a single dose of 1000 mg of acetaminophen orally after a baseline ultrasound and 60 minutes before a repeat ultrasound.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2 (34 patients)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pregnant women will be given a single dose of 1000 mg of acetaminophen orally 30 minutes to 24 hours before a scheduled cesarean section.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Arm 1 (20 patients)</intervention_name>
    <description>Acetaminophen 1000 mg by mouth once</description>
    <arm_group_label>Arm 1 (20 patients)</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Arm 2 (34 patients)</intervention_name>
    <description>Acetaminophen 1000 mg by mouth once</description>
    <arm_group_label>Arm 2 (34 patients)</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Pregnant females

          -  Age 18-44

          -  Any race

          -  Any parity

          -  Singleton Gestations

          -  Weight between 60-90 kg

        Exclusion Criteria

          -  Acetaminophen Allergy

          -  Contraindication to Acetaminophen Use

          -  Chorioamnionitis

          -  Preeclampsia

          -  Diabetes Mellitus

          -  Placental Abruption

          -  Placenta Previa

          -  Fetal Anomaly

          -  Intrauterine growth restriction (IUGR)

          -  Multiple Gestations

          -  Maternal Medical Disease

          -  Acetaminophen use in the last 3 days

          -  Plan to donate or bank fetal cord blood
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian C Brost, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 28, 2010</study_first_submitted>
  <study_first_submitted_qc>September 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2010</study_first_posted>
  <last_update_submitted>August 29, 2014</last_update_submitted>
  <last_update_submitted_qc>August 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Brian C. Brost, M.D.</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>Fetal movement</keyword>
  <keyword>Fetal breathing</keyword>
  <keyword>Acetaminophen</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

